Clinical trials
Insulin Resistance trials in Italy with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 2 |
| 2013 | 4 |
| 2014 | 2 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 4 |
| 2021 | 1 |
| 2022 | 4 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 23 |
| Unknown status | 6 |
| Recruiting | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Messina | 3 |
| Federico II University | 2 |
| Lo.Li.Pharma s.r.l | 2 |
| University of Campania Luigi Vanvitelli | 2 |
| University of Turin, Italy | 2 |
| Alice Andreassi | 1 |
| Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria | 1 |
| Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis | 1 |
| Azienda Ospedaliera Universitaria Integrata Verona | 1 |
| Azienda Ospedaliero Universitaria Maggiore della Carita | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Insulin Resistance | 32 |
| Obesity | 8 |
| Metabolic Syndrome | 4 |
| Overweight | 4 |
| Diabetes Mellitus, Type 2 | 3 |
| Diabetes, Gestational | 3 |
| Hyperglycemia | 2 |
| Inflammation | 2 |
| Anxiety Disorders | 1 |
| Arachnodactyly | 1 |
Trials
Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.